Table 3: COMORBIDITIES, N (%).
|
Comorbidity |
Overall Sample |
≤ 1 ED visits After WaaP |
≥ 2 ED Visits After WaaP |
P* |
|
Hypertension Yes No |
176 (47.2) 197 (52.8) |
153 (47.4) 170 (52.6) |
23 (46.0) 27 (54.0) |
< 0.001 |
|
Obesity Yes No |
166 (44.5) 207 (55.5) |
145 (44.9) 178 (55.1) |
21 (42.0) 29 (58.0) |
< 0.001 |
|
Tobacco Use Yes No |
144 (38.6) 229 (61.4) |
114 (35.3) 209 (64.7) |
30 (60.0) 20 (40.0) |
< 0.001 |
|
Rhinitis Yes No |
112 (30.0) 261 (70.0) |
101 (31.3) 222 (68.7) |
11 (22.0) 39 (78.0) |
< 0.001 |
|
GERD Yes No |
72 (19.3) 301 (80.7) |
65 (20.1) 258 (79.9) |
7 (14.0) 43 (86.0) |
< 0.001 |
|
Diabetes Yes no |
66 (17.7) 307 (82.3) |
59 (18.3) 264 (81.7) |
7 (14.0) 43 (86.0) |
< 0.001 |
|
Atopy Yes No |
36 (9.7) 337 (90.3) |
30 (9.3) 293 (90.7) |
6 (12.0) 44 (88.0) |
< 0.001 |
|
Illicit Drug Use Yes No |
35 (9.4) 338 (90.6) |
27 (8.4) 296 (91.6) |
8 (16.0) 42 (84.0) |
< 0.001 |
|
COPD Yes No |
42 (11.3) 331 (88.7) |
32 (9.9) 291 (90.1) |
10 (20.0) 40 (80.0) |
0.02 |
|
|
|
|
|
|
|
Depression Yes No |
14 (3.8) 359 (96.2) |
13 (4.0) 310 (96.0) |
1 (2.0) 49 (98.0) |
0.049 |
|
OSA Yes No |
13 (3.5) 360 (96.5) |
11 (3.4) 312 (96.6) |
2 (4.0) 48 (96.0) |
0.010 |
|
Alcohol Use Yes No |
27 (7.2) 346 (92.8) |
22 (6.8) 301 (93.2) |
5 (10.0) 45 (90.0) |
0.60 |
|
CHF1 Yes No |
18 (4.8) 355 (95.2) |
16 (5.0) 307 (95.0) |
2 (4.0) 48 (96.0) |
0.499 |
This table illustrates the comorbidities that exist in our patient population and their relationship with DECREASE in ED use.
*p-values were calculated using Pearson chi-square to indicate statistical significance of the relation of the acomorbidity to decreased ED visits